These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 25064452)
21. A novel alginate hollow fiber bioreactor process for cellular therapy applications. Hoesli CA; Luu M; Piret JM Biotechnol Prog; 2009; 25(6):1740-51. PubMed ID: 19768776 [TBL] [Abstract][Full Text] [Related]
22. Tissue engineering of osteochondral constructs in vitro using bioreactors. Haasper C; Zeichen J; Meister R; Krettek C; Jagodzinski M Injury; 2008 Apr; 39 Suppl 1():S66-76. PubMed ID: 18313474 [TBL] [Abstract][Full Text] [Related]
24. The role of bioreactors in tissue engineering. Martin I; Wendt D; Heberer M Trends Biotechnol; 2004 Feb; 22(2):80-6. PubMed ID: 14757042 [TBL] [Abstract][Full Text] [Related]
25. Cell culture models of higher complexity in tissue engineering and regenerative medicine. James Kirkpatrick C; Fuchs S; Iris Hermanns M; Peters K; Unger RE Biomaterials; 2007 Dec; 28(34):5193-8. PubMed ID: 17761278 [TBL] [Abstract][Full Text] [Related]
26. Construction of a multicoaxial hollow fiber bioreactor. McClelland R; Tech K; Macdonald JM Methods Mol Biol; 2013; 1001():215-26. PubMed ID: 23494433 [TBL] [Abstract][Full Text] [Related]
28. Review: bioreactor design towards generation of relevant engineered tissues: focus on clinical translation. Ravichandran A; Liu Y; Teoh SH J Tissue Eng Regen Med; 2018 Jan; 12(1):e7-e22. PubMed ID: 28374578 [TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of three-dimensional fluid flow in rotating bioreactors for tissue engineering. Botchwey EA; Pollack SR; Levine EM; Johnston ED; Laurencin CT J Biomed Mater Res A; 2004 May; 69(2):205-15. PubMed ID: 15057993 [TBL] [Abstract][Full Text] [Related]
30. Computational fluid dynamics for improved bioreactor design and 3D culture. Hutmacher DW; Singh H Trends Biotechnol; 2008 Apr; 26(4):166-72. PubMed ID: 18261813 [TBL] [Abstract][Full Text] [Related]
31. Meeting the needs of monitoring in tissue engineering. Mather ML; Morgan SP; Crowe JA Regen Med; 2007 Mar; 2(2):145-60. PubMed ID: 17465747 [TBL] [Abstract][Full Text] [Related]
32. Effects of pulsatile bioreactor culture on vascular smooth muscle cells seeded on electrospun poly (lactide-co-ε-caprolactone) scaffold. Mun CH; Jung Y; Kim SH; Kim HC; Kim SH Artif Organs; 2013 Dec; 37(12):E168-78. PubMed ID: 23834728 [TBL] [Abstract][Full Text] [Related]
34. In vitro human tissue models--moving towards personalized regenerative medicine. Schenke-Layland K; Nerem RM Adv Drug Deliv Rev; 2011 Apr; 63(4-5):195-6. PubMed ID: 21600252 [TBL] [Abstract][Full Text] [Related]
35. Visualizing feasible operating ranges within tissue engineering systems using a "windows of operation" approach: a perfusion-scaffold bioreactor case study. McCoy RJ; O'Brien FJ Biotechnol Bioeng; 2012 Dec; 109(12):3161-71. PubMed ID: 22627891 [TBL] [Abstract][Full Text] [Related]
36. Design and characterization of a rotating bed system bioreactor for tissue engineering applications. Anton F; Suck K; Diederichs S; Behr L; Hitzmann B; van Griensven M; Scheper T; Kasper C Biotechnol Prog; 2008; 24(1):140-7. PubMed ID: 18198883 [TBL] [Abstract][Full Text] [Related]
37. Perspectives on the advanced control of bioreactors for functional vascular tissue engineering in vitro. Couet F; Mantovani D Expert Rev Med Devices; 2012 May; 9(3):233-9. PubMed ID: 22702253 [TBL] [Abstract][Full Text] [Related]
38. Biomaterials in co-culture systems: towards optimizing tissue integration and cell signaling within scaffolds. Battiston KG; Cheung JW; Jain D; Santerre JP Biomaterials; 2014 May; 35(15):4465-76. PubMed ID: 24602569 [TBL] [Abstract][Full Text] [Related]
39. Large scale industrialized cell expansion: producing the critical raw material for biofabrication processes. Kumar A; Starly B Biofabrication; 2015 Nov; 7(4):044103. PubMed ID: 26539629 [TBL] [Abstract][Full Text] [Related]